Basit öğe kaydını göster

dc.contributor.authorSerdaroglu, Esra
dc.contributor.authorKuskonmaz, Baris
dc.contributor.authorAlanay, Yasemin
dc.contributor.authorAytac, Selin
dc.contributor.authorCetin, Mualla
dc.contributor.authorUckan Cetinkaya, Duygu
dc.date.accessioned2020-10-21T11:28:50Z
dc.date.available2020-10-21T11:28:50Z
dc.date.issued2018
dc.identifier.issn1536-3678
dc.identifier.urihttp://hdl.handle.net/11655/22993
dc.identifier.urihttps://doi.org/10.1097/MPH.0000000000000969
dc.description.abstractKlinefelter syndrome is characterized by gynecomastia, hypogonadism, small testes, elevated levels of follicle-stimulating hormone and an extra X chromosome (ie, 47,XXY).1 These patients tend to have an increased risk of developing male breast cancer and mediastinal germ cell tumors.2,3 Hematologic malignancies including acute or chronic leukemia are also observed in these patients,4 but only a few case reports with Klinefelter syndrome who developed myelodysplastic syndrome (MDS) were published.4–7tr_TR
dc.language.isoentr_TR
dc.publisherLippincott Williams & Wilkins
dc.relation.isversionof10.1097/MPH.0000000000000969tr_TR
dc.rightsinfo:eu-repo/semantics/openAccesstr_TR
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectMyelodysplastic Syndrometr_TR
dc.subjectKlinefelter Syndrometr_TR
dc.titleHematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome in a Child With Klinefelter Syndrome.tr_TR
dc.typeinfo:eu-repo/semantics/articletr_TR
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalJournal of Pediatric Hematology/Oncologytr_TR
dc.contributor.departmentÇocuk Sağlığı ve Hastalıklarıtr_TR
dc.identifier.volume40tr_TR
dc.identifier.issue1tr_TR
dc.identifier.startpage81tr_TR
dc.identifier.endpage82tr_TR
dc.description.indexWoStr_TR
dc.fundingYoktr_TR


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess